Produced by Liver Specialists of Texas, this is Part 1 of a series of hepatitis C educational classes for patients preparing to start hepatitis C therapy, using Interferon and Ribavirin, as well as the new protease inhibitor, boceprevir, available as Victrelis. The series will review background information about the function of the liver, diseases that are common to the liver, the natural history of hepatitis C, as well as treatment options. Management of the side effects of hepatitis C therapy will be stressed in the couse.